Robuta

https://www.cancer.gov/news-events/press-releases/2018/tailorx-breast-cancer-chemotherapy TAILORx finds no chemotherapy benefit for most early breast cancers - NCI Findings from the TAILORx clinical trial show chemotherapy does not benefit most women with early breast cancer. The new data, released at the 2018 ASCO annual... chemotherapy benefitbreast cancersfinds https://www.sciencedaily.com/releases/2015/11/151130182514.htm Black women less likely to benefit from early chemotherapy, study shows | ScienceDaily Among minority women treated with early chemotherapy, black women fare worse than the other groups, new research shows. While the cause of this is not known,... black womenless likely https://www.cuimc.columbia.edu/news/biomarker-predicts-which-stage-ii-colon-cancer-patients-may-benefit-chemotherapy Biomarker Predicts Which Stage II Colon Cancer Patients May Benefit from Chemotherapy | Columbia... Jul 10, 2019 - Researchers have identified a biomarker that predicts which stage II colon cancer patients may benefit from adjuvant chemotherapy.